| Financial Year |
March 31 2023 |
| Monetary Funds |
1,539,075,111.31 |
| Held-for-trading Financial Assets |
1,868,387,051.36 |
| Notes Receivable |
696,323,825.34 |
| Accounts Receivable |
1,861,993,210.89 |
| Advances to Suppliers |
618,759,534.26 |
| Other Receivables |
101,784,548.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,142,860,265.57 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
18,028,803.68 |
| Total Current Assets |
11,754,130,292.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
697,096,611.76 |
| Investment Properties |
76,656,497.21 |
| Fixed Assetes |
309,932,570.44 |
| Under-construction Projects |
154,033,423.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
118,555,229.93 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
42,924,508.74 |
| Deferred Income Tax Assets |
44,076,654.59 |
| Other Non-Current Assets |
28,794,130.00 |
| Sub-Total of Non-Current Assets |
1,511,830,478.54 |
| Total Assets |
13,265,960,771.10 |
| Short-Term Loans |
203,503,583.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,033,115,238.17 |
| Accounts Payable |
2,492,206,239.47 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
85,365,911.79 |
| Taxes Payable |
132,037,577.39 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
102,526,164.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
510,995,129.33 |
| Other Current Liabilities |
506,179,220.42 |
| Sub-Total of Current Liabilities |
7,728,569,565.02 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,106,450.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
102,237,173.76 |
| Total Liabilities |
7,830,806,738.78 |
| Paid-In Capital(Or Share Stock) |
499,566,000.00 |
| Capital Surplus |
2,559,154,328.89 |
| Surplus Reserve |
249,783,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,062,949,252.96 |
| Minority Stockholder's Interest |
64,394,689.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,370,759,342.71 |
| Owner's Equity（Stockholder's Equity） |
5,435,154,032.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,265,960,771.10 |
